Jennifer Lachey

Insider Reports History

Location
Lexington, MA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Lachey:

Company Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. Chief Scientific Officer Common Stock 95,100 $4,307,079 $45.29 15 Jul 2022 Direct
Keros Therapeutics, Inc. Chief Scientific Officer of Shares Employee Stock Option (right to buy) 76,705 04 Apr 2022 Direct
Keros Therapeutics, Inc. Chief Scientific Officer Employee Stock Option (right to buy) 8,755 15 Jul 2022 Direct

Insider Reports Filed by Jennifer Lachey

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KROS Keros Therapeutics, Inc. 15 Jul 2022 3 -$1,367,210 4 Chief Scientific Officer 19 Jul 2022, 16:40
KROS Keros Therapeutics, Inc. 13 Jul 2022 3 -$56,905 4 Chief Scientific Officer 15 Jul 2022, 16:40
KROS Keros Therapeutics, Inc. 14 Jun 2022 2 +$2,820 4 Chief Scientific Officer 14 Jun 2022, 18:57
KROS Keros Therapeutics, Inc. 11 May 2022 7 -$220,460 4 Chief Scientific Officer 13 May 2022, 16:37
KROS Keros Therapeutics, Inc. 11 Apr 2022 6 -$331,115 4 Chief Scientific Officer 13 Apr 2022, 16:36
KROS Keros Therapeutics, Inc. 04 Apr 2022 3 -$474,615 4 Chief Scientific Officer 06 Apr 2022, 16:49
KROS Keros Therapeutics, Inc. 11 Mar 2022 5 -$140,654 4 Chief Scientific Officer 15 Mar 2022, 16:37
KROS Keros Therapeutics, Inc. 11 Feb 2022 5 -$137,170 4 Chief Scientific Officer 15 Feb 2022, 15:26
KROS Keros Therapeutics, Inc. 21 Jan 2022 1 $0 4 Chief Scientific Officer 25 Jan 2022, 15:14
KROS Keros Therapeutics, Inc. 11 Jan 2022 5 -$141,652 4 Chief Scientific Officer 13 Jan 2022, 15:39
KROS Keros Therapeutics, Inc. 05 Jan 2022 3 -$158,205 4 Chief Scientific Officer 07 Jan 2022, 15:35
KROS Keros Therapeutics, Inc. 13 Dec 2021 8 -$132,763 4 Chief Scientific Officer 15 Dec 2021, 15:48
KROS Keros Therapeutics, Inc. 10 Nov 2021 7 -$1,263,698 4 Chief Scientific Officer 12 Nov 2021, 15:40
KROS Keros Therapeutics, Inc. 04 Nov 2021 3 -$526,820 4 Chief Scientific Officer 05 Nov 2021, 17:06
KROS Keros Therapeutics, Inc. 17 Aug 2021 2 +$388 4 Chief Scientific Officer 18 Aug 2021, 17:21
KROS Keros Therapeutics, Inc. 24 Jun 2021 2 +$1,950 4 Chief Scientific Officer 25 Jun 2021, 18:29
KROS Keros Therapeutics, Inc. 11 Jun 2021 5 -$134,292 4 Chief Scientific Officer 15 Jun 2021, 17:02
KROS Keros Therapeutics, Inc. 11 May 2021 7 -$130,871 4 Chief Scientific Officer 13 May 2021, 16:36